Home › Research › Cognitive tests and assessment
The Influence of a Specialized Dementia Ward on the Treatment of Alzheimer’s Disease Patients
YoungSoon Yang, Kyoon Huh, Yong Tae Kwak. Journal of Personalized Medicine, 2025-02-25
Topic: Risk, prevention and care in population studies
Plain-language summary
No statistically significant differences emerged between SDW and GW groups regarding baseline demographics, cognitive function, ADL, or neuropsychiatric symptoms. At four weeks, both groups exhibited trends toward improved K-MMSE, RAI-MDS, and NPI-Q scores and reduced psychotropic usage, but these did not reach statistical significance. Although mean length of stay was shorter for SDW patients (3.2 vs. 4.9 months; p = 0.078), the difference was not significant. Notably, a significantly higher proportion of SDW patients were discharged home (58.8% vs. 37.5%; p = 0.049). Although clinical outcomes were comparable, the SDW demonstrated advantages in facilitating discharge to home, suggesting that tailored ward environments may better support AD patients. These findings underscore the importance of therapeutic environments in dementia care and highlight the need for further research on specialized dementia ward designs to improve outcomes and patient satisfaction.
What this study adds
Evidence grade: Low
In this comparison of a specialized dementia ward with a general ward, there were no statistically significant differences in cognitive function, activities of daily living, or neuropsychiatric symptoms at four weeks, and the shorter length of stay was not significant. Reported effect size: 58.8%; 37.5%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Yang, Y., Huh, K., & Kwak, Y. T. (2025). The Influence of a Specialized Dementia Ward on the Treatment of Alzheimer’s Disease Patients. Journal of Personalized Medicine. https://doi.org/10.3390/jpm15030082
Vancouver
Yang Y, Huh K, Kwak YT. The Influence of a Specialized Dementia Ward on the Treatment of Alzheimer’s Disease Patients. Journal of Personalized Medicine. 2025. doi:10.3390/jpm15030082. PMID: 40137398.
BibTeX
@article{yang2025-40137398,
author = {Yang, YoungSoon and Huh, Kyoon and Kwak, Yong Tae},
title = {{The Influence of a Specialized Dementia Ward on the Treatment of Alzheimer’s Disease Patients}},
journal = {Journal of Personalized Medicine},
year = {2025},
doi = {10.3390/jpm15030082},
pmid = {40137398},
url = {https://doi.org/10.3390/jpm15030082}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- No statistically significant differences emerged between SDW and GW groups regarding baseline demographics, cognitive function, ADL, or neuropsychiatric symptoms.
- At four weeks, both groups exhibited trends toward improved K-MMSE, RAI-MDS, and NPI-Q scores and reduced psychotropic usage, but these did not reach statistical significance.
- Although mean length of stay was shorter for SDW patients (3.2 vs. 4.9 months; p = 0.078), the difference was not significant.
- Notably, a significantly higher proportion of SDW patients were discharged home (58.8% vs. 37.5%; p = 0.049).
- Although clinical outcomes were comparable, the SDW demonstrated advantages in facilitating discharge to home, suggesting that tailored ward environments may better support AD patients.
Why it matters
In this comparison of a specialized dementia ward with a general ward, there were no statistically significant differences in cognitive function, activities of daily living, or neuropsychiatric symptoms at four weeks, and the shorter length of stay was not significant. A significantly higher proportion of specialized ward patients were discharged home, so the main finding is about discharge destination rather than treating or curing Alzheimer's disease.
Study details
- Effect size58.8%; 37.5%
- Evidence strengthLow
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Personalized Medicine) |
| Journal's citation record | 1 / 4 | Journal of Personalized Medicine: journal h-index 96 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Yong Tae Kwak: h-index 15 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Soonchunhyang University: institution h-index 265 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40137398) |
| Free to read | 2 / 2 | Free to read |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/jpm15030082
- PubMed: 40137398
- Original source →
- Free full text: Journal of Personalized Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.